A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

Clinical trial NCT07768345 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07768345
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2026-08-31
Primary completion: 2028-02-02
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.